Up-regulation of telomere-binding proteins, TRF1, TRF2, and TIN2 is related to telomere shortening during human multistep hepatocarcinogenesis

被引:121
作者
Oh, BK
Kim, YJ
Park, C
Park, YN
机构
[1] Yonsei Univ, Coll Med, Ctr Chron Metab Dis Res, Dept Pathol, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea
关键词
D O I
10.1016/S0002-9440(10)62233-X
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The telomeric repeat-binding factor 1 (TRF1), TRF2, and the TRF1-interacting nuclear protein 2 (TIN2) are involved in telomere maintenance. We describe the regulation of expression of these genes along with their relationship to telomere length in hepatocarcinogenesis. The transcriptional expression of these genes, TRF1 protein, and telomere length was examined in 9 normal livers, 14 chronic hepatitis, 24 liver cirrhosis, 5 large regenerative nodules, 14 low-grade dysplastic nodules (DNs), 7 high-grade DNs, 10 DNs with hepatocellular carcinoma (HCC) foci, and 31 HCCs. The expression of TRF1, TRF2, TIN2 mRNA, and TRF1 protein was gradually increased according to the progression of hepatocarcinogenesis with a marked increase in high-grade DNs and DNs with HCC foci and a further increase in HCCs. There was a gradual shortening of telomere during hepatocarcinogenesis with a significant reduction in length in DNs. Most nodular lesions (52 of 67) had shorter telomeres than their adjacent chronic hepatitis or liver cirrhosis, and the telomere lengths were inversely correlated with the mRNA level of these genes (P less than or equal to 0.001). This was more evident in DNs and DNs with HCC foci. In conclusion, TRF1, TRF2, and TIN2 might be involved in multistep hepatocarcinogenesis by playing crucial roles in telomere shortening.
引用
收藏
页码:73 / 80
页数:8
相关论文
共 43 条
  • [1] Ancelin K, 1998, BIOESSAYS, V20, P879, DOI 10.1002/(SICI)1521-1878(199811)20:11<879::AID-BIES2>3.3.CO
  • [2] 2-9
  • [3] Targeting assay to study the cis functions of human telomeric proteins:: Evidence for inhibition of telomerase by TRF1 and for activation of telomere degradation by TRF2
    Ancelin, K
    Brunori, M
    Bauwens, S
    Koering, CE
    Brun, C
    Ricoul, M
    Pommier, JP
    Sabatier, L
    Gilson, E
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (10) : 3474 - 3487
  • [4] Switching and signaling at the telomere
    Blackburn, EH
    [J]. CELL, 2001, 106 (06) : 661 - 673
  • [5] Mammalian telomeres and telomerase
    Collins, K
    [J]. CURRENT OPINION IN CELL BIOLOGY, 2000, 12 (03) : 378 - 383
  • [6] Mammalian telomeres end in a large duplex loop
    Griffith, JD
    Comeau, L
    Rosenfield, S
    Stansel, RM
    Bianchi, A
    Moss, H
    de Lange, T
    [J]. CELL, 1999, 97 (04) : 503 - 514
  • [7] Balancing instability: dual roles for telomerase and telomere dysfunction in tumorigenesis
    Hackett, JA
    Greider, CW
    [J]. ONCOGENE, 2002, 21 (04) : 619 - 626
  • [8] Telomerase activity and telomere length in human hepatocellular carcinoma
    Huang, GT
    Lee, HS
    Chen, CH
    Chiou, LL
    Lin, YW
    Lee, CZ
    Chen, DS
    Sheu, JC
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 (12) : 1946 - 1949
  • [9] Hytiroglou P, 1998, CANCER, V82, P1831, DOI 10.1002/(SICI)1097-0142(19980515)82:10<1831::AID-CNCR4>3.3.CO
  • [10] 2-H